CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,044 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02738281
NCT02738281N/ACompleted

Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol

University of Alabama at Birmingham·observational·Posted Apr 14, 2016·Updated Aug 5, 2021

In Brief

An observational study for Rett Syndrome and 3 related conditions. Completed, enrolled 1,044 participants across 14 sites.

Detailed Summary

The purpose of this study is to advance understanding of the natural history of Rett syndrome (RTT), MECP2-duplication disorder (MECP2 Dup), CDKL5, FOXG1, and individuals with MECP2 mutations who do not have RTT including the range of clinical involvement and to correlate genotype-phenotype over a broad spectrum of phenotypes. While much has been learned about RTT, improvements are required in understanding the role of factors such as X chromosome inactivation, genetic background, and others including the environment, on the great variability observed even between individuals with the same MECP2 mutation. These data will be essential to the development and conduct of clinical trials that are anticipated from ongoing studies in animal models for RTT. This study will not include clinical trials, but should set the stage for such trials and other translational research projects (e.g., development of biomarkers).

Study Details

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 14, 2016
Enrollment StartNov 1, 2015
Primary CompletionJul 31, 2021
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 10.2 years ago